✨
AI Summary
- Herantis Pharma CEO discusses unmet needs in Parkinson's disease.
- Overview of Phase II plans for HER-096, a Parkinson's treatment.
- Details on the company's 'elegant' approach to Parkinson's.
Guests on This Episode
AV
Antti Vuolanto
1 podcast appearance